MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers

Journal of Surgical Research

Volumn 81, Issue 2, 1999, Pages 189-195

  Nwomeh, Benedict C ^a   Liang, Hui Xiu ^a   Cohen, I Kelman ^a   Yager, Dorne R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic wounds; Matrix metalloproteinases; Neutrophil; Wound healing

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGENASE; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NEUTROPHIL; PRIORITY JOURNAL; SURGICAL WOUND; ULCER; WOUND HEALING;

EID: 0033079612     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5495     Document Type: Article

References (36)

1. Bullen, E. C., Longaker, M. T., Updike, D. L., Benton, R., Ladin, D., Hou, Z., and Howard, E. W. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J. Invest. Dermatol. 104: 236, 1995.
2. Grinnell, F., Ho, C. H., and Wysocki, A. Degradation of fibronectin and vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting, and cell adhesion assays. J. Invest. Dermatol. 98: 410, 1992.
3. Harris, I. R., Yee, K. C., Walters, C. E., Cunliffe, W. J., Kearney, J. N., Wood, E. J., and Ingham, E. Cytokine and protease levels in healing and non-healing chronic venous leg ulcers. Exp. Dermatol. 4: 342, 1995.
4. Wysocki, A. B., and Grinnell, F. Fibronectin profiles in normal and chronic wound fluid. Lab. Invest 63: 825, 1990.
5. Yager, D. R., Zhang, L. Y., Liang, H. X., Diegelmann, R. F., and Cohen, I. K. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J. Invest Dermatol. 107: 743, 1996.
6. Vaalamo, M., Mattila, L., Johansson, N., Kariniemi, A. L., Karjalainen-Lindsberg, M. L., Kahari, V. M., and Saarialho-Kere, U. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol. 109: 96, 1997.
7. Stacy, M. C., Burnand, K. G., Mahmoud Alexandroni, M., Gaffney, P. J., and Bhogal, B. S. Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers. Br. J. Surg. 80: 596, 1993.
8. Rogers, A. A., Burnett, S., Moore, J. C., Shakespeare, P. G., and Chen, W. Y. J. Involvement of proteolytic enzymes - plasminogen activators and matrix metalloproteinases - in the pathophysiology of pressure ulcers. Wound Rep. Reg. 3: 273, 1995.
9. Grinnell, F., and Zhu, M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α-proteinase inhibitor, and α2-macroglobulin. J. Invest. Dermatol. 106: 335, 1996.
10. Wysocki, A. B., Staiano-Coico, L., and Grinnell, F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 101: 64, 1993.
11. Vaalamo, M., Weckroth, M., Puolakkainen, P., Kere, J., Saarinen, P., Lauharanta, J., and Saarialho-Kere, U. K. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br. J. Dermatol. 135: 52, 1996.
12. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248, 1976.
13. Dioszegi, M., Cannon, P., and Van Wart, H. E. Vertebrate collagenases. Methods Enzymol. 248: 413, 1995.
14. Horwitz, A. L., Hance, A. J., and Crystal, R. G. Granulocyte collagenase: Selective digestion of type I relative to type III collagen. Proc. Natl. Acad. Sci. USA 74: 897, 1977.
15. Netzel-Arnett, S., Fields, G. B., Birkedal-Hansen, H., Van Wart, H. E., and Fields, G. Sequence specificities of human fibroblast and neutrophil collagenases. J. Biol. Chem. 266: 6747, 1991.
16. Nagase, H., Ogata, Y., Suzuki, K., Enghild, J. J., and Salvesen, G. Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem. Soc. Trans. 19: 715, 1991.
17. Mallya, S. K., Mookhtiar, K. A., Gao, Y., Brew, K., Dioszegi, M., Birkedal-Hansen, H., and Van Wart, H. E. Characterization of 58-kilodalton human neutrophil collagenase: Comparison with human fibroblast collagenase. Biochemistry 29: 10628, 1990.
18. Hasty, K. A., Jeffrey, J. J., Hibbs, M. S., and Welgus, H. G. The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262: 10048, 1987.
19. Aiba, T., Akeno, N., Kawane, T., Okamoto, H., and Horiuchi, N. Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur. J. Oral Sci. 104: 562, 1996.
20. Birkedal-Hansen, H. Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64: 474, 1993.
21. Ray, J. M., and Stetler-Stevenson, W. G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7: 2062, 1994.
22. Tyagi, S. C. Proteinases and myocardial extracellular matrix turnover. Mol. Cell. Biochem. 168: 1, 1997.
23. Woessner, J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145, 1991.
24. Reynolds, J. J., Hembry, R. M., and Meikle, M. C. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv. Dent. Res. 8: 312, 1994.
25. Martel-Pelletier, J., McCollum, R., Fujimoto, N., Obata, K., Cloutier, J. M., and Pelletier, J. P. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab. Invest. 70: 807, 1994.
26. Brown, P. D. Matrix metalloproteinase inhibitors in the treatment of cancer. Med. Oncol. 14: 1, 1997.
27. Stricklin, G. P., Li, L., Jancic, V., Wenczak, B. A., and Nanney, L. B. Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am. J. Pathol. 143: 1657, 1993.
28. Stricklin, G. P., Li, L., and Nanney, L. B. Localization of mRNAs representing interstitial collagenase, 72-kDa gelatinase, and TIMP in healing porcine burn wounds. J. Invest. Dermatol. 103: 352, 1994.
29. Saarialho-Kere, U. K., Pentland, A. P., Birkedal-Hansen, H., Parks, W. C., and Welgus, H. G. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J. Clin. Invest. 94: 79, 1994.
30. Welgus, H. G., Jeffrey, J. J., and Eisen, A. Z. The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem. 256: 9511, 1981.
31. Johansson, N., Saarialho-Kere, U., Airola, K., Herva, R., Nissinen, L., Westermarck, J., Vuorio, E., Heino, J., and Kahari, V. M. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn. 208: 387, 1997.
32. Grinnell, F., and Zhu, M. Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J. Invest. Dermatol. 103: 155, 1994.
33. Rao, C. N., Ladin, D. A., Liu, Y. Y., Chilukuri, K., Hou, Z. Z., and Woodley, D. T. α1-Antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: The inhibitor protects fibronectin from degradation by chronic would fluid enzymes. J. Invest. Dermatol. 105: 572, 1995.
34. Yager, D. R., Chen, S. M., Ward, B. S., Olutoye, O. O., Diegelmann, R. F., and Cohen, I. K. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Rep. Reg. 5: 23, 1997.
35. Cole, A. A., Chubinskaya, S., Schumacher, B., Huch, K., Szabo, G., Yao, J., Mikecz, K., Hasty, K. A., and Kuettner, K. E. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J. Biol. Chem. 271: 11023, 1996.
36. Witkowski, J. A., and Parish, L. C. Histopathology of the decubitus ulcer. J. Am. Acad. Dermatol. 6: 1014, 1982.